Skip to main content
Erschienen in: Herz 2/2013

01.03.2013 | Original article

Platelet distribution width and saphenous vein disease in patients after CABG

Association with graft occlusion

verfasst von: Dr. M.R. Ege, U. Guray, Y. Guray, S. Acıkgoz, B. Demirkan

Erschienen in: Herz | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Objective

Platelets are involved in the pathogenesis of atherosclerosis. The inflammatory process in atherosclerosis may cause an increase in red blood cell distribution width (RDW) and platelet distribution width (PDW) values. Therefore, in this study we aimed to investigate whether PDW and RDW are associated with the patency of saphenous vein graft in patients at least 1 year after coronary artery bypass graft (CABG) surgery.

Methods

Patients who had undergone CABG surgery at least 1 year previously with at least one saphenous vein graft were included in the study population. Patients were referred to cardiac catheterization for stable anginal symptoms or positive stress test results. Before coronary angiography, all patients referred had routine blood tests including RDW and PDW values.

Results

Saphenous vein grafts were found to be patent in 69 patients and occluded in 40 patients. Although RDW levels were similar between patients with patent and occluded grafts (13.1 ± 1.1% and 13.2 ± 0.7% respectively, p = 0.37), PDW levels were significantly different between the two groups (13.1 ± 1.3% and 14.1 ± 1.1 respectively, p = 0.03). Although time after CABG operation differs significantly between the two groups (p < 0.001), multiple logistic regression analyses showed that PDW levels were found to be significantly associated with the patency of vein graft (β = 1.682, 95% CI 1.117–2.532, p = 0.013).

Conclusion

Our results showed that PDW levels were higher in patients with an occluded saphenous vein graft. However no association was found between the saphenous vein graft disease and RDW values. To verify this relationship between PDW values and saphenous vein graft patency, further investigations are needed.
Literatur
1.
Zurück zum Zitat Eagle KA, Guyton RA, Davidoff R et al (1999) ACC/AHA guidelines for coronary artery bypass graft surgery: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery). American College of Cardiology/American Heart Association. J Am Coll Cardiol 34:1262–1347PubMedCrossRef Eagle KA, Guyton RA, Davidoff R et al (1999) ACC/AHA guidelines for coronary artery bypass graft surgery: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery). American College of Cardiology/American Heart Association. J Am Coll Cardiol 34:1262–1347PubMedCrossRef
2.
Zurück zum Zitat Parang P, Arora R (2009) Coronary vein graft disease: pathogenesis and prevention. Can J Cardiol 25:e57–62PubMedCrossRef Parang P, Arora R (2009) Coronary vein graft disease: pathogenesis and prevention. Can J Cardiol 25:e57–62PubMedCrossRef
3.
Zurück zum Zitat Angelini GD, Newby AC (1989) The future of saphenous vein as a coronary artery bypass conduit. Eur Heart J 10:273–280PubMed Angelini GD, Newby AC (1989) The future of saphenous vein as a coronary artery bypass conduit. Eur Heart J 10:273–280PubMed
4.
Zurück zum Zitat Perkins SL (2003) Examination of blood and bone marrow. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraksevas F, Glader BE (eds) Wintrobe’s clinical hematology. 11th ed. Lipincott Wilkins and Williams, Salt Lake City, UT, USA, pp 5–25 Perkins SL (2003) Examination of blood and bone marrow. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraksevas F, Glader BE (eds) Wintrobe’s clinical hematology. 11th ed. Lipincott Wilkins and Williams, Salt Lake City, UT, USA, pp 5–25
5.
Zurück zum Zitat Felker GM, Allen LA, Pocock SJ et al (2007) Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM program and the Duke databank. J Am Coll Cardiol 50:40–47PubMedCrossRef Felker GM, Allen LA, Pocock SJ et al (2007) Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM program and the Duke databank. J Am Coll Cardiol 50:40–47PubMedCrossRef
6.
Zurück zum Zitat Fukuta H, Ohte N, Mukai S et al (2009) Elevated plasma levels of B-type natriuretic Peptide but not C-reactive protein are associated with higher red cell distribution width in patients with coronary artery disease. Int Heart J 50:301–312PubMedCrossRef Fukuta H, Ohte N, Mukai S et al (2009) Elevated plasma levels of B-type natriuretic Peptide but not C-reactive protein are associated with higher red cell distribution width in patients with coronary artery disease. Int Heart J 50:301–312PubMedCrossRef
7.
Zurück zum Zitat Cavusoglu E, Chopra V, Gupta A et al (2010) Relation between red blood cell distribution width (RDW) and all-cause mortality at two years in an unselected population referred for coronary angiography. Int J Cardiol 141:141–146PubMedCrossRef Cavusoglu E, Chopra V, Gupta A et al (2010) Relation between red blood cell distribution width (RDW) and all-cause mortality at two years in an unselected population referred for coronary angiography. Int J Cardiol 141:141–146PubMedCrossRef
8.
Zurück zum Zitat Dabbah S, Hammerman H, Markiewicz W, Aronson D (2010) Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol 105:312–317PubMedCrossRef Dabbah S, Hammerman H, Markiewicz W, Aronson D (2010) Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol 105:312–317PubMedCrossRef
9.
Zurück zum Zitat Trip MD, Cats VM, Capelle FJ van, Vreeken J (1990) Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 322:1549–1554PubMedCrossRef Trip MD, Cats VM, Capelle FJ van, Vreeken J (1990) Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 322:1549–1554PubMedCrossRef
10.
Zurück zum Zitat Fuentes QE, Fuentes QF, Andrés V et al (2012) Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis. Platelets [Epub ahead of print] Fuentes QE, Fuentes QF, Andrés V et al (2012) Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis. Platelets [Epub ahead of print]
11.
Zurück zum Zitat Ozkan B, Uysal OK, Duran M et al (2012) Relationship between mean platelet volume and atherosclerosis in young patients with ST elevation myocardial infarction. Angiology [Epub ahead of print] Ozkan B, Uysal OK, Duran M et al (2012) Relationship between mean platelet volume and atherosclerosis in young patients with ST elevation myocardial infarction. Angiology [Epub ahead of print]
12.
Zurück zum Zitat Murat SN, Duran M, Kalay N et al (2012) Relation between mean platelet volume and severity of atherosclerosis in patients with acute coronary syndromes. Angiology [Epub ahead of print] Murat SN, Duran M, Kalay N et al (2012) Relation between mean platelet volume and severity of atherosclerosis in patients with acute coronary syndromes. Angiology [Epub ahead of print]
13.
Zurück zum Zitat De Luca G, Venegoni L, Iorio S et al (2010) Platelet distribution width and the extent of coronary artery disease: results from a large prospective study. Platelets 21:508–514CrossRef De Luca G, Venegoni L, Iorio S et al (2010) Platelet distribution width and the extent of coronary artery disease: results from a large prospective study. Platelets 21:508–514CrossRef
14.
Zurück zum Zitat Halabi AR, Alexander JH, Shaw LK et al (2005) Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery. Am J Cardiol 96:1254–1259PubMedCrossRef Halabi AR, Alexander JH, Shaw LK et al (2005) Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery. Am J Cardiol 96:1254–1259PubMedCrossRef
15.
Zurück zum Zitat Angelini GD, Newby AC (1989) The future of saphenous vein as a coronary artery bypass conduit. Eur Heart J 10:273–280PubMed Angelini GD, Newby AC (1989) The future of saphenous vein as a coronary artery bypass conduit. Eur Heart J 10:273–280PubMed
16.
Zurück zum Zitat Parang P, Arora R (2009) Coronary vein graft disease: pathogenesis and prevention. Can J Cardiol 25:e57–62PubMedCrossRef Parang P, Arora R (2009) Coronary vein graft disease: pathogenesis and prevention. Can J Cardiol 25:e57–62PubMedCrossRef
17.
Zurück zum Zitat Tefferi A, Hanson CA, Inwards DJ (2005) How to interpret and pursue an abnormal complete blood cell count in adults. Mayo Clin Proc 80:923–936PubMedCrossRef Tefferi A, Hanson CA, Inwards DJ (2005) How to interpret and pursue an abnormal complete blood cell count in adults. Mayo Clin Proc 80:923–936PubMedCrossRef
18.
Zurück zum Zitat Kimmenade RR van, Mohammed AA, Uthamalingam S et al (2010) Red blood cell distribution width and 1-year mortality in acute heart failure. Eur J Heart Fail 12:129–136PubMedCrossRef Kimmenade RR van, Mohammed AA, Uthamalingam S et al (2010) Red blood cell distribution width and 1-year mortality in acute heart failure. Eur J Heart Fail 12:129–136PubMedCrossRef
19.
Zurück zum Zitat Tonelli M, Sacks F, Arnold M et al (2008) Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 117:163–168PubMedCrossRef Tonelli M, Sacks F, Arnold M et al (2008) Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 117:163–168PubMedCrossRef
20.
Zurück zum Zitat Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105:1135–1143PubMedCrossRef Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105:1135–1143PubMedCrossRef
21.
Zurück zum Zitat Pierce CN, Larson DF (2005) Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion 20:83–90PubMedCrossRef Pierce CN, Larson DF (2005) Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion 20:83–90PubMedCrossRef
22.
Zurück zum Zitat Uyarel H, Ergelen M, Cicek G et al (2011) Red cell distribution width as a novel prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction. Coron Artery Dis 22:138–144PubMedCrossRef Uyarel H, Ergelen M, Cicek G et al (2011) Red cell distribution width as a novel prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction. Coron Artery Dis 22:138–144PubMedCrossRef
23.
Zurück zum Zitat Thaulow E, Erikssen J, Sandvik L et al (1991) Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 84:613–617PubMedCrossRef Thaulow E, Erikssen J, Sandvik L et al (1991) Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 84:613–617PubMedCrossRef
24.
Zurück zum Zitat Massberg S, Brand K, Grüner S et al (2002) A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 196:887–896PubMedCrossRef Massberg S, Brand K, Grüner S et al (2002) A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 196:887–896PubMedCrossRef
25.
Zurück zum Zitat Bigalke B, Schuster A, Sopova K et al (2012) Platelets in Atherothrombosis: diagnostic and prognostic value of platelet activation in patients with atherosclerotic diseases. Curr Vasc Pharmacol [Epub ahead of print] Bigalke B, Schuster A, Sopova K et al (2012) Platelets in Atherothrombosis: diagnostic and prognostic value of platelet activation in patients with atherosclerotic diseases. Curr Vasc Pharmacol [Epub ahead of print]
26.
Zurück zum Zitat Martin JF, Bath PM, Burr ML (1991) Influence of platelet size on outcome after myocardial infarction. Lancet 338:1409–1411PubMedCrossRef Martin JF, Bath PM, Burr ML (1991) Influence of platelet size on outcome after myocardial infarction. Lancet 338:1409–1411PubMedCrossRef
27.
Zurück zum Zitat Thompson CB, Eaton KA, Princiotta SM et al (1982) Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol 50(3):509–519PubMedCrossRef Thompson CB, Eaton KA, Princiotta SM et al (1982) Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol 50(3):509–519PubMedCrossRef
28.
Zurück zum Zitat Thompson CB, Jakubowski JA, Quinn PG et al (1983) Platelet size as a determinant of platelet function. J Lab Clin Med 101:205–213PubMed Thompson CB, Jakubowski JA, Quinn PG et al (1983) Platelet size as a determinant of platelet function. J Lab Clin Med 101:205–213PubMed
29.
Zurück zum Zitat Brown AS, Hong Y, Belder A de et al (1997) Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol 17:802–807PubMedCrossRef Brown AS, Hong Y, Belder A de et al (1997) Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol 17:802–807PubMedCrossRef
30.
Zurück zum Zitat Huo Y, Schober A, Forlow SB et al (2003) Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 9:61–67PubMedCrossRef Huo Y, Schober A, Forlow SB et al (2003) Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 9:61–67PubMedCrossRef
31.
Zurück zum Zitat Gawaz M, Stellos K, Langer HF (2008) Platelets modulate atherogenesis and progression of atherosclerotic plaques via interaction with progenitor and dendritic cells. J Thromb Haemost 6:235–242PubMed Gawaz M, Stellos K, Langer HF (2008) Platelets modulate atherogenesis and progression of atherosclerotic plaques via interaction with progenitor and dendritic cells. J Thromb Haemost 6:235–242PubMed
32.
Zurück zum Zitat Lindemann S, Krämer B, Daub K et al (2007) Molecular pathways used by platelets to initiate and accelerate atherogenesis. Curr Opin Lipidol 18:566–573PubMedCrossRef Lindemann S, Krämer B, Daub K et al (2007) Molecular pathways used by platelets to initiate and accelerate atherogenesis. Curr Opin Lipidol 18:566–573PubMedCrossRef
33.
Zurück zum Zitat Yilmaz MB, Cihan G, Guray Y et al (2008) Role of mean platelet volume in triagging acute coronary syndromes. J Thromb Thrombolysis 26:49–54PubMedCrossRef Yilmaz MB, Cihan G, Guray Y et al (2008) Role of mean platelet volume in triagging acute coronary syndromes. J Thromb Thrombolysis 26:49–54PubMedCrossRef
34.
Zurück zum Zitat Chu H, Chen WL, Huang CC et al (2011) Diagnostic performance of mean platelet volume for patients with acute coronary syndrome visiting an emergency department with acute chest pain: the Chinese scenario. Emerg Med J 28:569–574PubMedCrossRef Chu H, Chen WL, Huang CC et al (2011) Diagnostic performance of mean platelet volume for patients with acute coronary syndrome visiting an emergency department with acute chest pain: the Chinese scenario. Emerg Med J 28:569–574PubMedCrossRef
35.
Zurück zum Zitat Vagdatli E, Gounari E, Lazaridou E et al (2010) Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia 14:28–32PubMed Vagdatli E, Gounari E, Lazaridou E et al (2010) Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia 14:28–32PubMed
36.
Zurück zum Zitat Bourassa MG, Fisher LD, Campeau L et al (1985) Circulation. Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences. Circulation 72:V71–78PubMed Bourassa MG, Fisher LD, Campeau L et al (1985) Circulation. Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences. Circulation 72:V71–78PubMed
37.
Zurück zum Zitat Desai ND, Cohen EA, Naylor CD et al (2004) A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts. N Engl J Med 351:2302–2309PubMedCrossRef Desai ND, Cohen EA, Naylor CD et al (2004) A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts. N Engl J Med 351:2302–2309PubMedCrossRef
38.
Zurück zum Zitat Cho KR, Kim JS, Choi JS, Kim KB (2006) Serial angiographic follow-up of grafts one year and five years after coronary artery bypass surgery. Eur J Cardiothorac Surg 29:511–516PubMedCrossRef Cho KR, Kim JS, Choi JS, Kim KB (2006) Serial angiographic follow-up of grafts one year and five years after coronary artery bypass surgery. Eur J Cardiothorac Surg 29:511–516PubMedCrossRef
Metadaten
Titel
Platelet distribution width and saphenous vein disease in patients after CABG
Association with graft occlusion
verfasst von
Dr. M.R. Ege
U. Guray
Y. Guray
S. Acıkgoz
B. Demirkan
Publikationsdatum
01.03.2013
Verlag
Urban and Vogel
Erschienen in
Herz / Ausgabe 2/2013
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-012-3668-z

Weitere Artikel der Ausgabe 2/2013

Herz 2/2013 Zur Ausgabe

Übersichtsarbeit

Hypertonie und Ernährung

VHF-Ablation nützt wohl nur bei reduzierter Auswurfleistung

02.05.2024 Ablationstherapie Nachrichten

Ob die Katheterablation von Vorhofflimmern bei Patienten mit Herzinsuffizienz die Komplikationsraten senkt, scheint davon abzuhängen, ob die Auswurfleistung erhalten ist oder nicht. Das legen die Ergebnisse einer Metaanalyse nahe.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Weniger Extremitätenischämien mit dualer Plättchenhemmung

02.05.2024 Thrombozytenaggregationshemmer Nachrichten

Eine Behandlung mit Ticagrelor zusätzlich zu ASS kann das Risiko für Revaskularisierungen und Amputationen von Extremitäten bei Diabetikern mit stabiler KHK deutlich reduzieren, vor allem für solche mit PAVK. Dafür spricht eine Auswertung der Interventionsstudie THEMIS.

Beutel versus Maschine: Beste Beatmungstechnik bei Herzstillstand gesucht

02.05.2024 Kardiopulmonale Reanimation Nachrichten

Stehen die Chancen auf eine Rückkehr der Spontanzirkulation nach Herz-Kreislauf-Stillstand bei manueller oder maschineller Beatmung besser? Und unterscheidet sich das neurologische Outcome nach der Reanimation? Das belgische Herzstillstand-Register liefert die Daten für einen direkten Vergleich zwischen Beutel und Beatmungsgerät.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.